Sorrento to merge with gene-encoded therapies firm SmartPharm

SmartPharm is developing non-viral DNA and RNA gene delivery platforms for Covid-19 and rare diseases. Credit: Pete Linforth from Pixabay.



  • Sorrento; SmartPharm